Furthermore, recent studies highlight a novel connection between PRMT5 and polo-like kinase 4 (PLK4) in AML with TP53 mutations, wherein PRMT5 phosphorylation modulates leukemic cell survival and proliferation [71]. This evidence concerns the gene PRMT5 and acute myeloid leukemia.